Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches.

TimesSquare Capital U.S. Mid Cap Growth Strategy featured stocks like Cencora, Inc. (NYSE:COR) in the Q4 2023 investor letter.Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (NYSE:COR ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

TimesSquare Capital Management U.S. Focus Growth Strategy highlighted stocks like Cencora, Inc. (NYSE:COR), in the second quarter 2024 investor letter.Cencora, Inc. (NYSE:COR) sources and ...

Cencora Inc (COR) reports a 13% revenue increase and raises full-year guidance, driven by robust US healthcare solutions and strategic market positioning.

Cencora Inc. (NYSE:COR), a leading player in the U.S. Healthcare Technology & Distribution sector, has been drawing significant attention from analysts due to its robust performance and strategic ...

Cencora increases FY2025 EPS guidance to $15.70-$15.95 amid specialty growth May 07, 2025 10:57 AM ET Cencora, Inc. (COR) Stock AI-Generated Earnings Calls Insights Play ( 6min ) ...

According to the press release announcing the change, the name Cencora is inspired by AmerisourceBergen customers and more than 44,000 employees around the world.

Cencora, Inc. (NYSE:COR) Q4 2023 Results Conference Call November 2, 2023 8:30 AM ETCompany ParticipantsBennett Murphy - SVP, Head IR and TreasurySteve ...

Drug distributor Cencora has entered into a definitive agreement to acquire Retina ... "We are pleased to enter our next phase of growth with the support of a leading global pharmaceutical solutions ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #3 ...